The invention discloses a supramolecule
assembly of targeting-delivery anticancer adamplatin. The supramolecule
assembly is a binary supramolecule
assembly which is synthesized on the basis of
cyclodextrin-decorated
hyaluronic acid and adamplatin. A preparation method of the supramolecule assembly is characterized in that the
cyclodextrin-decorated
hyaluronic acid and the adamplatin are respectively synthesized, and through the strong non-
covalent interaction of
cyclodextrin and adamantine and the amphiphilic action of molecules, a
supermolecule nano particle which takes the hydrophilic
hyaluronic acid as a shell and the adamplatin as a core is formed. The supramolecule assembly disclosed by the invention has the advantages that the supramolecule assembly of the targeting-delivery anticancer adamplatin has a simple synthetic
route, is low in preparation cost and high in productivity, and is suitable for amplification synthesis and practical production application; and through
endocytosis in which a malignant
cell surface hyaluronic acid
receptor serves as a medium, the supramolecule assembly (HAP) is brought in
cancer cells in a target manner, so that the protection of normal cells and the targeting selective killing of
cancer cells are realized, the anti-
cancer activity is obviously improved, and toxic and side effects are obviously reduced.